Clinical Approach to Abnormal Movements

Pediatric Neurology Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of abnormal movements in children

Abnormal movements are a common reason for pediatric neurology referral, affecting approximately 3-5% of children at some point during childhood. Movement disorders in children represent a diverse group of conditions characterized by involuntary movements, abnormal postures, or difficulty initiating and controlling voluntary movements. Unlike adults, pediatric movement disorders often have unique etiologies including genetic conditions, metabolic diseases, and developmental abnormalities, making accurate classification and diagnosis essential for appropriate management.

Key Epidemiology

Tics: Most common movement disorder in children — affects 10-20% of school-age children transiently; Tourette syndrome affects 0.3-1%
Stereotypies: Primary motor stereotypies occur in 3-4% of typically developing children
Dystonia: Prevalence of approximately 2-50 per million for primary dystonia; secondary forms more common
Chorea: Sydenham chorea accounts for 90% of acquired childhood chorea in endemic regions
Tremor: Essential tremor affects 0.4-6% of children; enhanced physiological tremor is more common

Definition

Abnormal movements (movement disorders) encompass a heterogeneous group of neurological conditions characterized by either excessive involuntary movements (hyperkinetic disorders) or paucity/slowness of movement (hypokinetic disorders). In pediatrics, hyperkinetic disorders predominate, while hypokinetic disorders such as parkinsonism are rare but increasingly recognized.

Classification by Movement Phenomenology

The cornerstone of evaluating abnormal movements is accurate phenomenological classification. Each movement type has distinct characteristics that guide differential diagnosis and management.

Movement Type	Key Characteristics	Speed	Pattern	Suppressibility
Tics	Brief, sudden, repetitive movements or vocalizations; preceded by premonitory urge; temporarily suppressible	Fast	Stereotyped, patterned	Temporarily suppressible
Chorea	Irregular, unpredictable, flowing movements that migrate from one body part to another; “dance-like”	Fast	Random, non-patterned	Not suppressible
Dystonia	Sustained or intermittent muscle contractions causing abnormal postures and/or repetitive twisting movements	Slow to sustained	Patterned, directional	Not voluntarily suppressible
Tremor	Rhythmic, oscillatory movement around a fixed axis	Variable	Rhythmic, regular	Not suppressible
Myoclonus	Brief, shock-like jerks due to sudden muscle contraction (positive) or inhibition (negative)	Very fast	Irregular or rhythmic	Not suppressible
Stereotypies	Repetitive, rhythmic, patterned movements that are purposeless but appear purposeful; suppressible with distraction	Variable	Highly stereotyped	Suppressible with distraction
Athetosis	Slow, writhing, continuous movements predominantly affecting distal limbs	Slow	Continuous, flowing	Not suppressible
Ballismus	Large-amplitude, flinging movements of proximal limbs; considered severe chorea	Fast	Proximal, flinging	Not suppressible

Classification by Temporal Pattern

Temporal Pattern	Duration/Course	Common Etiologies in Children	Clinical Implications
Acute Onset	Hours to days	Drug-induced (metoclopramide, antipsychotics), infection/post-infectious, stroke, intoxication, autoimmune encephalitis	Requires urgent evaluation; often reversible if identified early
Subacute	Days to weeks	Sydenham chorea, autoimmune conditions, paraneoplastic syndromes, Wilson disease	Consider autoimmune and metabolic workup
Chronic Progressive	Months to years with worsening	Neurodegenerative diseases, neurometabolic disorders, brain tumors	Requires extensive metabolic and genetic evaluation
Chronic Stable/Non-progressive	Stable over time	Cerebral palsy, static encephalopathy, primary tics, stereotypies, essential tremor	May not require extensive workup if examination consistent
Paroxysmal	Episodic with normal intervals	Paroxysmal dyskinesias, episodic ataxias, alternating hemiplegia of childhood	Video documentation essential; genetic testing often diagnostic

Classification by Etiology

Primary (Idiopathic/Genetic)

Definition: Movement disorder is the only or main clinical feature, typically genetic in origin

Primary dystonia (DYT genes)
Primary tic disorders/Tourette syndrome
Essential tremor
Primary stereotypies
Benign hereditary chorea
Paroxysmal dyskinesias

Secondary (Acquired/Symptomatic)

Definition: Movement disorder results from identifiable brain injury, infection, metabolic derangement, or other cause

Cerebral palsy (perinatal injury)
Post-infectious (Sydenham chorea)
Drug-induced dyskinesias
Autoimmune encephalitis
Structural lesions (stroke, tumor)
Metabolic disorders (Wilson disease)

Classification by Age of Onset

Age Group	Common Movement Disorders	Key Considerations
Neonates (0-28 days)	Jitteriness, neonatal seizures (may mimic movements), benign neonatal sleep myoclonus, hyperekplexia, drug withdrawal	Distinguish from seizures; consider metabolic causes, hypoxic-ischemic injury, inborn errors of metabolism
Infants (1-12 months)	Infantile spasms, benign myoclonus of early infancy, shuddering attacks, dystonic reactions, Sandifer syndrome	Normal developmental movements (startle, Moro) versus pathological; consider early-onset dystonia syndromes
Toddlers (1-3 years)	Stereotypies, breath-holding spells with movements, early tics, spasmus nutans, paroxysmal torticollis of infancy	Stereotypies often emerge; developmental regression suggests neurodegenerative disease
Preschool/School-age (4-12 years)	Tics (peak onset 5-7 years), Sydenham chorea, PANDAS/PANS, functional movement disorders	Tics most common; post-streptococcal disorders; increasing recognition of functional disorders
Adolescents (13-18 years)	Essential tremor, Wilson disease presentation, juvenile Huntington disease, functional movement disorders	Wilson disease screen mandatory for new movement disorder; psychogenic considerations

Classification by Body Distribution

Distribution	Definition	Clinical Examples
Focal	Affecting a single body region	Cervical dystonia, writer’s cramp, blepharospasm, hemifacial spasm
Segmental	Two or more contiguous body regions	Cranial-cervical dystonia, brachial dystonia
Multifocal	Two or more non-contiguous body regions	Tics affecting face and arm separately
Generalized	Trunk plus at least two other regions	Generalized dystonia, generalized chorea
Hemidystonia/Hemichorea	Affecting one side of the body	Often indicates contralateral structural lesion (stroke, tumor)

Key Concept — The Pediatric Difference:

Developing nervous system: Movement phenomenology may evolve as the brain matures; dystonia in cerebral palsy often becomes more prominent with age
Genetic predominance: Unlike adults, genetic and metabolic causes are much more common in pediatric movement disorders
Mixed phenotypes: Children more commonly have combinations of movement disorders (dystonia-parkinsonism, chorea-dystonia)
Diagnostic opportunity: Early identification may allow disease-modifying treatment (Wilson disease, dopa-responsive dystonia)
Functional impact: Movement disorders significantly affect motor development, education, and psychosocial wellbeing

Impact on Function and Quality of Life

Movement disorders in children have wide-ranging effects beyond the movements themselves:

Physical Impact

Motor milestone delays
Difficulty with fine motor tasks (writing, feeding)
Speech and swallowing difficulties
Falls and injuries
Fatigue and pain (especially dystonia)

Psychosocial Impact

Social stigma and bullying
Academic difficulties
Anxiety and depression (especially tics)
Family stress
Reduced participation in activities

Clinical Pearl: Video Documentation

Movement disorders are often intermittent or variable. Home video recordings by parents are invaluable for diagnosis. Request videos of typical episodes, movements during various activities, and movements during sleep (tics and stereotypies typically disappear during sleep; myoclonus may persist).

2. Pathophysiology and Mechanisms

Understanding the neural circuits underlying abnormal movements in children

Understanding the neuroanatomical and neurochemical basis of movement disorders is essential for clinical reasoning. The basal ganglia serve as the central hub for movement regulation, with distinct circuits involved in different movement phenomenologies. In children, the developing brain adds complexity, as injury at different developmental stages produces varying phenotypes.

The Basal Ganglia Motor Circuit

The basal ganglia integrate cortical inputs to modulate movement through direct and indirect pathways. Disruption of these circuits underlies most hyperkinetic and hypokinetic movement disorders.

Structure	Primary Neurotransmitter	Function in Motor Control	Disorders When Affected
Striatum (Caudate + Putamen)	GABA (output); receives dopamine, glutamate	Input station; integrates cortical information; initiates movement selection	Chorea (Huntington, Sydenham), dystonia, tics
Globus Pallidus Externa (GPe)	GABA	Part of indirect pathway; inhibits subthalamic nucleus	Dystonia, chorea
Globus Pallidus Interna (GPi)	GABA	Major output nucleus; inhibits thalamus	Dystonia, parkinsonism; target for deep brain stimulation
Subthalamic Nucleus (STN)	Glutamate (excitatory)	Excites GPi; “brake” on movement	Hemiballismus (lesion causes contralateral ballismus)
Substantia Nigra pars compacta (SNc)	Dopamine	Modulates striatal activity via D1 and D2 receptors	Parkinsonism (dopamine deficiency)
Substantia Nigra pars reticulata (SNr)	GABA	Output nucleus similar to GPi; projects to superior colliculus and thalamus	Dystonia
Thalamus (VA/VL nuclei)	Glutamate	Relay to motor cortex; final common pathway for basal ganglia output	Various movement disorders depending on input disruption

Direct and Indirect Pathways

Direct Pathway (Movement Facilitation)

Net effect: Promotes movement

Circuit:

Cortex → Striatum (D1 receptors)
Striatum inhibits GPi/SNr
Reduced inhibition of thalamus
Increased thalamocortical excitation
Result: Movement facilitated

Dysfunction: Underactivity causes hypokinesia

Indirect Pathway (Movement Inhibition)

Net effect: Suppresses unwanted movement

Circuit:

Cortex → Striatum (D2 receptors)
Striatum inhibits GPe
GPe disinhibition of STN
STN excites GPi/SNr
Result: Movement suppressed

Dysfunction: Underactivity causes hyperkinesia

Simplified Model of Hyperkinetic vs Hypokinetic Disorders:

Hyperkinetic disorders (chorea, dystonia, tics): Reduced GPi output → thalamic disinhibition → excessive cortical activation
Hypokinetic disorders (parkinsonism): Increased GPi output → excessive thalamic inhibition → reduced cortical activation

Note: This is an oversimplification; dystonia, for example, involves complex network dysfunction rather than simple pathway imbalance.

Pathophysiology by Movement Type

Movement Type	Primary Neural Mechanism	Key Structures Involved	Neurotransmitter Imbalance
Tics	Dysfunction of cortico-striato-thalamo-cortical circuits; impaired inhibitory control; sensorimotor integration abnormalities	Striatum (especially caudate), supplementary motor area, anterior cingulate cortex	Dopamine excess/dysregulation; GABA deficiency in striatum
Chorea	Loss of striatal medium spiny neurons (especially indirect pathway); reduced GPe → STN inhibition	Striatum, GPe, STN	Dopamine relative excess; GABA deficiency; glutamate excess
Dystonia	Loss of inhibition at multiple levels; abnormal sensorimotor integration; impaired surround inhibition; abnormal plasticity	Striatum, GPi, cerebellum, sensorimotor cortex	Variable; dopamine deficiency (dopa-responsive dystonia); acetylcholine excess
Tremor	Oscillatory activity in cerebello-thalamo-cortical circuits; abnormal timing and synchronization	Cerebellum, thalamus (VIM nucleus), motor cortex	GABA dysfunction; noradrenergic involvement (enhanced physiological tremor)
Myoclonus	Hyperexcitable motor cortex (cortical myoclonus); brainstem reflex dysfunction (reticular myoclonus); spinal cord hyperexcitability	Motor cortex, brainstem reticular formation, spinal cord	GABA deficiency; serotonin dysregulation; glycine receptor dysfunction (hyperekplexia)
Stereotypies	Altered striatal development/function; possibly related to reward circuit involvement; self-stimulatory behavior	Striatum, frontal cortex	Dopamine and serotonin dysregulation hypothesized
Athetosis	Damage to striatum and/or thalamus, often perinatal; incomplete maturation of basal ganglia circuits	Putamen, thalamus	Variable; often mixed with other movement types in cerebral palsy
Ballismus	Lesion of subthalamic nucleus → loss of excitatory input to GPi → severe disinhibition of thalamus	Subthalamic nucleus	Glutamate deficiency in STN output

Mechanisms in Specific Pediatric Conditions

Cerebral Palsy — Dyskinetic Type

Pathophysiology of Dyskinetic Cerebral Palsy

Injury pattern: Selective vulnerability of basal ganglia (especially globus pallidus and thalamus) to hypoxic-ischemic injury, acute severe hyperbilirubinemia (kernicterus), or perinatal stroke

Mechanism: The basal ganglia are metabolically active and particularly sensitive to energy failure. Neonatal injury disrupts the normal maturation of basal ganglia circuits, leading to dystonia, chorea, and athetosis that often become more apparent as the child develops.

Clinical correlation: MRI typically shows bilateral T2 hyperintensity in globus pallidus in kernicterus; periventricular changes in hypoxic-ischemic injury

Sydenham Chorea

Autoimmune Mechanism

Post-streptococcal autoimmune response
Molecular mimicry: antibodies against streptococcal antigens cross-react with basal ganglia neurons
Targets include lysoganglioside and dopamine receptors
Anti-neuronal antibodies correlate with disease activity

Neuroimaging Correlates

Reversible striatal enlargement during acute phase
Increased signal in basal ganglia on T2-weighted MRI
Resolution of imaging abnormalities with clinical improvement
PET shows striatal hypometabolism

Dopa-Responsive Dystonia (Segawa Disease)

A Treatable Dystonia: Understanding the Mechanism

Genetic basis: Most commonly caused by autosomal dominant mutations in GCH1 (GTP cyclohydrolase 1), leading to deficiency of tetrahydrobiopterin (BH4)

Biochemical pathway:

BH4 is an essential cofactor for tyrosine hydroxylase
Tyrosine hydroxylase catalyzes the rate-limiting step in dopamine synthesis
BH4 deficiency → reduced dopamine synthesis in nigrostriatal pathway
Diurnal fluctuation: dopamine stores depleted with activity, partially replenished with sleep

Treatment implication: Low-dose levodopa provides substrate that bypasses the enzymatic block, resulting in dramatic and sustained improvement

Tic Disorders and Tourette Syndrome

Neural Component	Abnormality in Tic Disorders	Evidence
Striatal dysfunction	Reduced caudate volume; abnormal striatal metabolism	MRI volumetric studies; PET/SPECT imaging
Dopaminergic system	Striatal dopamine dysregulation; increased dopamine release	Response to dopamine blockers; increased synaptic dopamine on imaging
Cortical inhibition	Impaired intracortical inhibition; reduced ability to suppress motor responses	Transcranial magnetic stimulation studies
Sensorimotor integration	Abnormal premonitory urge processing; heightened interoception	Functional MRI studies of urge perception

Developmental Considerations in Pediatric Movement Disorders

Why Movement Disorders Evolve in Children:

Basal ganglia maturation: Myelination and synaptogenesis continue through adolescence; injury effects may become apparent as circuits mature
Changing phenotype: A child with early hypotonia may develop dystonia by school age as corticospinal and extrapyramidal systems mature
Critical periods: Timing of injury affects phenotype — early injury often produces more generalized patterns while later injury may be more focal
Compensation: The developing brain has greater plasticity, allowing some compensation but also maladaptive changes
Unmasking: Some genetic conditions (e.g., Wilson disease, Huntington disease) may not manifest until sufficient neural degeneration occurs

Neurotransmitter Systems and Treatment Implications

Neurotransmitter	Role in Movement	Conditions with Dysregulation	Therapeutic Implications
Dopamine	Modulates direct/indirect pathway balance; facilitates movement initiation	Deficiency: parkinsonism, dopa-responsive dystonia. Excess: drug-induced dyskinesia, tics	Levodopa, dopamine agonists (deficiency); dopamine blockers (excess)
GABA	Primary inhibitory neurotransmitter; suppresses unwanted movements	Deficiency: chorea, myoclonus, dystonia, hyperekplexia	Benzodiazepines, baclofen, vigabatrin
Acetylcholine	Striatal interneurons; opposes dopamine effects	Relative excess in dopamine deficiency states; dystonia	Anticholinergics (trihexyphenidyl) for dystonia
Glutamate	Primary excitatory neurotransmitter; STN uses glutamate	Excess contributes to excitotoxicity and hyperkinesia	NMDA receptor antagonists (amantadine)
Serotonin	Modulates basal ganglia circuits; involved in tic pathophysiology	Tics, myoclonus, serotonin syndrome	SSRIs may help tics; serotonin syndrome causes myoclonus
Norepinephrine	Modulates motor activity; arousal effects on movement	Enhanced physiological tremor; tics	Alpha-2 agonists (clonidine, guanfacine) for tics

Clinical Pearl: The Cerebellum in Movement Disorders

While traditionally the basal ganglia have been the focus of movement disorder pathophysiology, there is growing recognition of the cerebellum’s role:

Tremor: The cerebello-thalamo-cortical circuit is central to tremor generation
Dystonia: Cerebellar dysfunction contributes to abnormal sensorimotor integration and timing
Myoclonus: The cerebellum is involved in cortical myoclonus through its connections

This has therapeutic implications, as the cerebellum is a potential target for non-invasive stimulation therapies.

Complications of Movement Disorders Themselves

Movement disorders can cause secondary problems beyond the movements:

Movement Type	Potential Complications	Mechanism
Severe dystonia	Contractures, skeletal deformities (scoliosis, hip subluxation), chronic pain, rhabdomyolysis in dystonic crisis	Sustained muscle contractions cause structural changes; severe episodes cause muscle breakdown
Chorea	Weight loss, falls, aspiration, exhaustion	Increased metabolic demand; swallowing incoordination; balance impairment
Tics	Self-injurious tics, social isolation, chronic pain from repetitive movements	Forceful tics can cause injury; social stigma; repetitive strain
Tremor	Functional impairment (writing, feeding), social embarrassment	Interference with fine motor tasks; visible abnormality
Myoclonus	Falls, injuries, inability to eat or drink safely	Sudden jerks disrupt posture and coordinated activities

3. History Taking

A comprehensive approach to eliciting the history of abnormal movements in children

Red Flags — Require Urgent Evaluation

Acute onset with altered consciousness — encephalitis, intoxication, metabolic crisis
Fever with movement disorder — infectious or autoimmune encephalitis, Sydenham chorea
Progressive neurological decline — neurodegenerative disease, tumor, metabolic disorder
Developmental regression — neurometabolic disease, neurodegenerative condition
Focal or unilateral movements — structural lesion (stroke, tumor, demyelination)

Recent medication exposure — acute dystonic reaction, neuroleptic malignant syndrome
Status dystonicus — sustained severe dystonia with risk of rhabdomyolysis, respiratory failure
Hepatosplenomegaly or Kayser-Fleischer rings — Wilson disease (treatable if caught early)
Movement disorder in adolescent — mandatory Wilson disease screening
Seizures with movement disorder — epileptic encephalopathy, progressive myoclonic epilepsy

Systematic History: The “MOVEMENTS” Approach

Use the mnemonic “MOVEMENTS” to ensure comprehensive history taking for pediatric movement disorders:

M — Movement description: What does it look like? Fast/slow? Rhythmic/random? Which body parts? Ask for video!
O — Onset and course: When did it start? Sudden or gradual? Getting better, worse, or stable?
V — Variability and triggers: What makes it better or worse? Stress? Sleep? Activity? Time of day?
E — Early development: Birth history, milestones, any regression? Previous normal development?
M — Medications and toxins: Current and recent medications? Metoclopramide? Antipsychotics? Exposures?
E — Eating and growth: Feeding difficulties? Weight changes? Swallowing problems?
N — Neurological symptoms: Seizures? Headaches? Vision changes? Weakness? Sensory changes?
T — Triggers and infections: Recent illness? Strep throat? Vaccinations? Trauma?
S — Social and family: Family history of movement disorders? Consanguinity? Impact on school/function?

Detailed History Components

Movement Characterization

Precise characterization of the movement is the foundation of diagnosis. Request home videos and observe the child during the consultation.

Question Category	Specific Questions to Ask	Diagnostic Significance
Appearance	“Can you describe or show me what the movement looks like?” “Is it jerky, flowing, twisting, or shaking?”	Differentiates tics (sudden, brief) from chorea (flowing) from dystonia (twisting, sustained) from tremor (oscillatory)
Speed	“Is the movement fast like a jerk or slow and sustained?”	Fast: tics, myoclonus, chorea. Slow: dystonia, athetosis
Rhythm	“Is there a regular beat to the movement or is it unpredictable?”	Rhythmic: tremor, stereotypies. Irregular: chorea, myoclonus. Patterned: tics, dystonia
Distribution	“Which body parts are affected? One side or both? Spreading to new areas?”	Hemidystonia suggests structural lesion; generalized suggests genetic/metabolic cause
Suppressibility	“Can your child stop the movement if asked? For how long?”	Temporarily suppressible: tics, stereotypies. Not suppressible: chorea, dystonia, myoclonus
Premonitory sensations	“Does your child feel something building up before the movement?”	Premonitory urge strongly suggests tics; absent in other movement disorders
Sleep persistence	“Does the movement continue during sleep?”	Disappears in sleep: tics, stereotypies, most chorea. May persist: myoclonus, severe dystonia

Temporal Pattern and Course

Suspected Pattern	Key Features	Ask This Question
Acute dystonic reaction	Hours after medication, sustained posturing, distress	“Has your child taken any new medications in the past 24-72 hours? Any anti-nausea medications?”
Sydenham chorea	Subacute onset, may follow sore throat by 1-6 months	“Has your child had a sore throat, skin infection, or documented strep infection in the past few months?”
Tic disorder	Waxing and waning course, onset typically 5-7 years	“Do the movements come and go? Are there good weeks and bad weeks? Do old movements disappear and new ones appear?”
Dopa-responsive dystonia	Diurnal fluctuation — worse in evening, better after sleep	“Is the movement worse in the evening compared to the morning? Does your child walk better after waking up?”
Paroxysmal dyskinesia	Episodic attacks with normal intervals	“Are there episodes where the movements suddenly start and then completely stop? How long do episodes last?”
Neurodegenerative disease	Progressive worsening, loss of previously acquired skills	“Could your child do things before that they can’t do now? Is there overall decline in function?”
Autoimmune encephalitis	Subacute onset with neuropsychiatric symptoms	“Have there been personality changes, sleep problems, confusion, or seizures along with the movements?”

Modifying Factors

Factors That May Worsen Movements

Stress and anxiety: Worsens tics, tremor, dystonia
Fatigue: Worsens most movement disorders
Activity/action: Action tremor, task-specific dystonia
Startle: Hyperekplexia, some myoclonus
Caffeine: Worsens tremor, tics
Sleep deprivation: Worsens most movements
Heat: May worsen dystonia
Illness/fever: Worsens most movements

Factors That May Improve Movements

Sleep: Tics, stereotypies disappear; chorea improves
Rest after sleep: Dopa-responsive dystonia
Distraction: Stereotypies, tics may decrease
Sensory tricks (geste antagoniste): Dystonia
Alcohol: Essential tremor, myoclonus-dystonia (note: for history only, not treatment)
Concentration on task: Some tics temporarily suppressed
Relaxation: Tremor, some dystonia

Clinical Pearl: Sensory Tricks (Geste Antagoniste)

A sensory trick is a specific maneuver that temporarily alleviates dystonia. Ask about these — their presence strongly supports a diagnosis of dystonia over other movement disorders:

Cervical dystonia: Touching chin or face may straighten the neck
Blepharospasm: Touching the face near the eyes may open them
Writer’s cramp: Using a larger pen or different grip may help

Birth and Developmental History

Critical in pediatric movement disorders — early brain injury is a common cause of secondary dystonia and other movement disorders.

History Component	Specific Questions	Relevance to Movement Disorders
Pregnancy	Infections during pregnancy? Medications? Substance use? Complications?	Congenital infections, teratogens, prenatal brain injury
Delivery	Gestational age? Birth weight? Mode of delivery? Complications?	Prematurity risk for cerebral palsy; birth asphyxia; kernicterus
Neonatal period	NICU admission? Ventilation? Jaundice needing phototherapy/exchange? Seizures? Feeding difficulties?	Hypoxic-ischemic encephalopathy; kernicterus causes dyskinetic cerebral palsy; early seizures suggest structural/metabolic cause
Motor milestones	Age at: head control, sitting, crawling, walking, running? Hand preference before age 2?	Delayed milestones suggest early brain injury or progressive condition; early hand preference suggests hemiparesis
Speech/language	First words? Sentences? Current speech clarity? Regression?	Dysarthria common with movement disorders; regression red flag for neurodegeneration
Cognitive development	Learning difficulties? School performance? Need for special education?	Cognitive impairment may indicate genetic syndrome or early brain injury
Regression	Has your child lost any skills they previously had? Walking? Talking? Feeding?	Red flag for neurodegenerative or neurometabolic disease

Associated Symptoms Review

Associated Symptom	Consider These Diagnoses
Behavioral changes, obsessions, anxiety	Tourette syndrome (often comorbid with obsessive-compulsive disorder and attention deficit hyperactivity disorder), autoimmune encephalitis, Wilson disease
Cognitive decline	Neurodegenerative disease (Huntington, Wilson, neuronal ceroid lipofuscinosis), mitochondrial disease
Seizures	Progressive myoclonic epilepsy, metabolic disorders, mitochondrial disease, autoimmune encephalitis
Ataxia	Ataxia-telangiectasia, spinocerebellar ataxias, mitochondrial disease, Wilson disease
Psychiatric symptoms	Wilson disease, Huntington disease, autoimmune encephalitis, PANDAS/PANS
Visual impairment	Neuronal ceroid lipofuscinosis, mitochondrial disease, pantothenate kinase-associated neurodegeneration
Hepatic dysfunction	Wilson disease, mitochondrial disease, organic acidemias
Dysphagia/drooling	Severe dystonia, cerebral palsy, Wilson disease, bulbar involvement

Medication and Toxin History

Medications That Cause Movement Disorders

Drug Class	Movement Caused	Timeline
Dopamine blockers (metoclopramide, prochlorperazine, antipsychotics)	Acute dystonic reaction, tardive dyskinesia, parkinsonism, akathisia	Acute: hours to days. Tardive: months to years
Anticonvulsants (phenytoin, carbamazepine, valproate)	Tremor, chorea (phenytoin toxicity), asterixis	Variable; often dose-related
Stimulants (methylphenidate, amphetamines)	Tics (may unmask or worsen), stereotypies	Days to weeks after starting
SSRIs and other antidepressants	Tremor, akathisia, myoclonus (serotonin syndrome)	Variable
Lithium	Tremor, chorea (toxicity)	Dose-related
Bronchodilators (salbutamol/albuterol)	Tremor	Hours after use

Toxin Exposures

Carbon monoxide: Delayed parkinsonism, dystonia (days to weeks after exposure)
Manganese: Parkinsonism (welding fumes, contaminated water)
Lead: Encephalopathy with movement abnormalities
Organophosphates: Cholinergic toxicity, fasciculations, tremor
Recreational drugs: MDMA, cocaine, synthetic cannabinoids can cause various movement disorders

Key Questions

“What medications is your child currently taking?”
“Any medications started in the past week?”
“Has your child been given anything for nausea or vomiting?”
“Any over-the-counter medications or supplements?”
“Any possible accidental ingestions?”

Family History

Genetic conditions are common causes of pediatric movement disorders. A detailed family history is essential:

Three-generation pedigree: Ask about movement disorders, tremor, “nervous habits,” psychiatric conditions in parents, siblings, grandparents, aunts, uncles
Consanguinity: Increases risk of autosomal recessive conditions (many metabolic and genetic movement disorders)
Ethnic background: Some conditions more common in certain populations (Wilson disease in Sardinia; Tay-Sachs in Ashkenazi Jewish)
Ask specifically about: Tics, tremor, dystonia, “clumsiness,” Parkinson disease, Huntington disease, early dementia, liver disease, psychiatric hospitalizations

Family History Finding	Consider These Conditions	Inheritance Pattern
Parent with similar movements	DYT1 dystonia, essential tremor, Tourette syndrome, benign hereditary chorea	Autosomal dominant (variable penetrance)
Affected siblings, unaffected parents	Wilson disease, neurometabolic disorders, dopa-responsive dystonia (can be recessive)	Autosomal recessive
Maternal inheritance pattern	Mitochondrial disease	Mitochondrial inheritance
Males affected, transmitted through females	Some dystonia syndromes, Lesch-Nyhan syndrome	X-linked
Early-onset parkinsonism in family	Parkin mutations, other genetic parkinsonism	Autosomal recessive
Huntington disease in family	Juvenile Huntington disease	Autosomal dominant with anticipation

Functional Impact Assessment

Understanding the impact on daily life helps guide treatment decisions and track progress.

Domain	Questions to Ask
Self-care	“Can your child feed themselves? Dress independently? Manage bathroom needs?”
Mobility	“How does your child get around? Any falls? Need for walking aids or wheelchair?”
Communication	“Is speech affected? Can others understand your child? Any difficulty swallowing?”
Education	“How are they doing at school? Any learning support? Can they write and keep up in class?”
Social	“Does the movement affect friendships? Any teasing or bullying? Avoiding activities?”
Emotional	“How does your child feel about the movements? Any anxiety, sadness, or embarrassment?”
Sleep	“Any trouble falling asleep or staying asleep? Do movements interfere with sleep?”
Pain	“Is there any pain associated with the movements? Where? How severe?”

Collateral History

In pediatric movement disorders, always obtain history from:

Parents/caregivers: Best source for developmental history, daily function, and observations during sleep
Teachers: May notice subtle difficulties, attention problems, social issues
The child: Older children can describe premonitory urges (tics), triggers, and psychosocial impact
Therapists: Physical, occupational, or speech therapists may have detailed functional observations

Request video recordings from home — movements may not be evident during clinic visit due to stress, unfamiliar environment, or natural fluctuation.

4. Physical Examination

A systematic approach to examining children with abnormal movements

Systematic Framework: Use the approach of “Observe, Then Examine” for pediatric movement disorders. Begin with observation during free play or unstructured activity, then proceed to formal neurological examination. Many movements are best observed when the child is distracted or engaged in natural activities.

General Observation

Observation begins the moment the child enters the room. Watch carefully before touching.

Observation	What to Look For	Clinical Significance
Spontaneous movements	Type, location, frequency, amplitude of abnormal movements at rest	Characterize the primary movement phenomenology
Posture	Head position, trunk alignment, limb posturing	Sustained posturing suggests dystonia; asymmetry suggests hemiparesis
Gait observation	Watch child walk into room; running; turning; tandem gait	Toe-walking, wide base, asymmetry, dystonic posturing
Interaction and behavior	Alertness, eye contact, engagement, anxiety level	Cognitive impairment, autism features, psychiatric comorbidity
Effect of attention	Movements when child is distracted versus focused	Tics and stereotypies may decrease with distraction; chorea and dystonia persist
Dysmorphic features	Facial features, body proportions, skin findings	May suggest specific genetic syndrome
Nutritional status	Weight, muscle bulk, cachexia	Poor growth may indicate chronic disease or feeding difficulties

Growth Parameters

Plot on Appropriate Growth Charts

Weight, height, head circumference: Calculate percentiles and plot on growth chart
Microcephaly: Head circumference below 2nd percentile — suggests early brain injury or genetic syndrome
Macrocephaly: Head circumference above 98th percentile — consider storage disorders, hydrocephalus, genetic syndromes
Poor weight gain: May indicate feeding difficulties, increased metabolic demand from movements, or systemic disease
Short stature: Consider metabolic conditions, growth hormone deficiency in some syndromes

Vital Signs

Age	Heart Rate (bpm)	Respiratory Rate (/min)	Systolic BP (mmHg)	Relevance to Movement Disorders
Neonate	100-160	30-60	60-90	Hypoglycemia, metabolic crisis
Infant (1-12 mo)	100-150	25-40	80-100	Tachycardia in thyrotoxicosis
Toddler (1-3 yr)	90-140	20-30	90-105	Fever suggests infectious etiology
Preschool (4-5 yr)	80-120	20-25	95-110	Hypertension in some encephalopathies
School age (6-12 yr)	70-110	18-25	100-120	Orthostatic changes in autonomic dysfunction
Adolescent (13-18 yr)	60-100	12-20	110-130	Similar to adult values

Specific Features to Examine

Skin Examination

Finding	Description	Associated Condition
Café-au-lait spots	Flat, light brown macules	Neurofibromatosis type 1 (may have movement disorder component)
Ash leaf spots	Hypopigmented macules (use Wood’s lamp)	Tuberous sclerosis complex
Telangiectasias	Dilated blood vessels, especially conjunctival and skin folds	Ataxia-telangiectasia (ataxia with chorea/dystonia)
Xanthomas	Yellowish skin deposits	Cerebrotendinous xanthomatosis
Icterus/jaundice	Yellow discoloration of skin and sclera	Wilson disease, liver involvement
Self-injurious wounds	Lip or finger biting injuries	Lesch-Nyhan syndrome (self-mutilation with dystonia)

Eye Examination

Finding	How to Examine	Associated Condition
Kayser-Fleischer rings	Slit-lamp examination required; golden-brown ring at corneal limbus	Wilson disease — MUST examine in any adolescent with movement disorder
Cherry-red spot	Fundoscopy — red fovea surrounded by pale macula	Tay-Sachs disease, GM1 gangliosidosis, sialidosis
Optic atrophy	Fundoscopy — pale optic disc	Neurodegeneration, mitochondrial disease
Retinitis pigmentosa	Fundoscopy — bone spicule pigmentation, attenuated vessels	Neuronal ceroid lipofuscinosis, mitochondrial disease, NBIA
Oculogyric crisis	Sustained upward and lateral eye deviation	Acute dystonic reaction, neurotransmitter disorders
Telangiectasias	Direct observation — dilated conjunctival vessels	Ataxia-telangiectasia
Impaired upgaze	Ask child to look up without moving head	Progressive supranuclear palsy (rare in children), Niemann-Pick type C
Slow saccades	Ask child to look quickly between two targets	Huntington disease, spinocerebellar ataxias

Mandatory: Slit-Lamp Examination for Wilson Disease

Any child or adolescent presenting with a new movement disorder (especially dystonia, tremor, parkinsonism, or chorea) MUST have a slit-lamp examination to look for Kayser-Fleischer rings. Wilson disease is treatable and potentially fatal if missed. Kayser-Fleischer rings are present in approximately 95% of patients with neurological Wilson disease.

Ear, Nose, and Throat

Pharyngitis: May indicate recent streptococcal infection (Sydenham chorea, PANDAS)
Tongue fasciculations: Suggest lower motor neuron involvement
Tongue dystonia: May cause dysarthria, feeding difficulties
Macroglossia: Storage disorders, hypothyroidism

Abdominal Examination

Hepatomegaly: Wilson disease, storage disorders, mitochondrial disease
Splenomegaly: Storage disorders (Gaucher, Niemann-Pick)
Ascites: Advanced Wilson disease with liver failure

Neurological Examination

Mental Status

Level of alertness: Encephalopathy suggests metabolic, infectious, or autoimmune cause
Cognitive assessment: Age-appropriate testing; formal neuropsychological evaluation if concerns
Speech: Dysarthria (muscle control), apraxia (motor planning), aphasia (language)
Behavioral observations: Tics, obsessive behaviors, attention, hyperactivity

Cranial Nerve Examination

Cranial Nerve	Relevant Findings	Clinical Significance
II (Optic)	Visual acuity, visual fields, fundoscopy	Optic atrophy in neurodegenerative conditions
III, IV, VI (Ocular motor)	Eye movements, saccades, pursuits, vergence	Oculogyric crisis; slow saccades in Huntington; vertical gaze palsy in Niemann-Pick C
V (Trigeminal)	Facial sensation, jaw strength	May be involved in brainstem lesions
VII (Facial)	Facial symmetry, strength, spontaneous movements	Facial dystonia, hemifacial spasm, facial tics
IX, X (Glossopharyngeal, Vagus)	Palate movement, gag reflex, swallowing	Bulbar dysfunction causes dysphagia; important in severe dystonia
XI (Accessory)	Shoulder shrug, head turning	Cervical dystonia affects these muscles
XII (Hypoglossal)	Tongue protrusion, movements, fasciculations	Tongue dystonia; fasciculations suggest lower motor neuron disease

Motor Examination

Tone Assessment

Spasticity: Velocity-dependent increased tone; clasp-knife phenomenon
Rigidity: Lead-pipe (constant) or cogwheel (with tremor); suggests parkinsonism
Dystonia: Variable tone with sustained posturing; may fluctuate
Hypotonia: Decreased resistance; floppy posture

Note: Children may have mixed tone patterns, especially in cerebral palsy.

Strength Testing

Test major muscle groups using age-appropriate methods
Weakness suggests pyramidal tract involvement or neuromuscular disease
May be difficult to assess accurately with dystonia
Document any asymmetry

Note: Many primary movement disorders have normal strength.

Reflexes

Deep tendon reflexes: Increased with upper motor neuron involvement; decreased in some metabolic conditions
Plantar response: Upgoing (Babinski) suggests corticospinal tract dysfunction
Primitive reflexes: Persistence beyond appropriate age suggests developmental delay or regression
Frontal release signs: May be present in degenerative conditions

Coordination and Cerebellar Function

Test	What to Look For	Significance
Finger-to-nose	Intention tremor, dysmetria	Cerebellar dysfunction; tremor worsens near target
Rapid alternating movements	Dysdiadochokinesia (irregular rate/rhythm)	Cerebellar involvement
Heel-to-shin	Wobbling along shin	Cerebellar ataxia
Romberg test	Increased sway with eyes closed	Proprioceptive loss (sensory ataxia)
Tandem gait	Difficulty walking heel-to-toe	Cerebellar or sensory ataxia

Gait Examination

Observe the child walking, running, turning, and walking on heels and toes.

Gait Pattern	Description	Suggests
Dystonic gait	Twisting, abnormal posturing of foot/leg during walking; may toe-walk	Dystonia — observe for diurnal variation (dopa-responsive)
Choreiform gait	Irregular, dance-like quality; stumbling; wide-based	Chorea
Parkinsonian gait	Small shuffling steps, reduced arm swing, stooped posture, difficulty turning	Parkinsonism (rare in children)
Ataxic gait	Wide-based, staggering, unable to tandem walk	Cerebellar dysfunction
Spastic gait	Stiff, scissoring; circumduction; toe-walking	Upper motor neuron involvement (cerebral palsy)
Worsening with exercise	Progressively abnormal gait with walking	Dopa-responsive dystonia (classically)

Characterizing the Movement During Examination

Activation Maneuvers

Movements may not be evident at rest. Use these techniques to bring out abnormal movements:

Maneuver	How to Perform	What It Reveals
Arm extension	Hold arms outstretched, fingers spread	Postural tremor, choreiform movements, dystonic posturing
Finger-to-nose with eyes closed	Touch nose with eyes closed	Intention tremor, dystonic drift
Writing sample	Ask child to write name, sentence, or draw spiral	Tremor, dystonia, micrographia
Drawing	Draw a spiral (Archimedes spiral)	Tremor amplitude and regularity
Pouring water	Pour water between cups (simulate if needed)	Action tremor severity
Mental distraction	Perform mental arithmetic or recite while observing	Chorea may increase; tics may briefly decrease then rebound
Motor overflow	Perform finger tapping with one hand while observing other	Mirror movements, overflow dystonia
Walking and talking	Walk while answering questions	Gait deterioration may unmask mild movement disorder

Specific Tests for Movement Types

For Suspected Tics

Ask about premonitory urge
Ask child to suppress tic (brief suppression possible)
Observe for rebound after suppression
Note waxing/waning during visit
Document motor AND phonic tics

For Suspected Dystonia

Look for sensory trick (geste antagoniste)
Check for task specificity
Assess effect of different postures
Look for “null point” (position where dystonia minimal)
Check for overflow to other body parts

Expected Findings by Etiology

Condition	Movement Type	Key Examination Findings	Associated Features
Tourette syndrome	Multiple motor and vocal tics	Tics suppressible briefly; may have premonitory urge; neurological exam otherwise normal	Often normal exam between tics; may see obsessive-compulsive behaviors
Sydenham chorea	Generalized chorea	“Milkmaid’s grip” (fluctuating grip); “darting tongue”; hypotonia; motor impersistence	May have cardiac findings (murmur); emotional lability
Dopa-responsive dystonia	Dystonia, often starting in legs	Dystonic gait; diurnal fluctuation (worse in PM); may have mild parkinsonism	Usually cognitively normal; family history possible
Wilson disease	Tremor, dystonia, chorea, parkinsonism	Kayser-Fleischer rings on slit-lamp; hepatomegaly; wing-beating tremor	Psychiatric symptoms; liver disease; may be subtle early
Dyskinetic cerebral palsy	Dystonia, chorea, athetosis	Mixed movement disorder; hypotonia or hypertonia; delayed motor milestones	History of perinatal event; may have oromotor dysfunction
Primary stereotypies	Stereotyped movements	Highly consistent pattern; suppressible; often hand flapping, waving	Normal neurological exam; normal development; may be seen in excitement
Essential tremor	Postural and kinetic tremor	6-12 Hz tremor; worse with action; may affect head, voice; no dystonia	Family history common; neurological exam otherwise normal
Juvenile Huntington disease	Rigidity, dystonia (more than chorea in juvenile form)	Bradykinesia; rigidity; eye movement abnormalities; seizures	Cognitive decline; behavioral changes; family history (may be unknown if parent not yet symptomatic)

Important Teaching Point

Mixed movement disorders are common in children. Unlike adults who often have “pure” movement disorders, children frequently present with combinations of:

Dystonia + chorea (dyskinetic cerebral palsy)
Dystonia + myoclonus (myoclonus-dystonia syndrome)
Tremor + dystonia (dystonic tremor)
Tics + stereotypies (may coexist)

Identify the predominant movement type to guide initial diagnostic workup.

Clinical Pearl: The “Stressed Parent” Sign

Pay attention to parental anxiety and the family’s coping. Excessive parental concern about benign movements (transient tics, stereotypies) may require as much attention as the movement itself. Conversely, parents may minimize significant movements that warrant investigation. Video review with families helps calibrate expectations.

Documentation

Thorough documentation is essential for tracking progression and response to treatment:

Document for Each Movement Disorder:

Type: Phenomenological classification (tic, chorea, dystonia, etc.)
Distribution: Focal, segmental, multifocal, generalized, hemibody
Severity: Mild, moderate, severe; consider using validated scales when available
Frequency: Constant, intermittent, paroxysmal
Activation: At rest, with action, with specific tasks
Associated neurological signs: Tone, reflexes, strength, coordination
Functional impact: Effect on daily activities, school, social participation

5. Differential Diagnosis

Systematic approach organized by movement type, probability, and clinical features

The differential diagnosis of pediatric movement disorders begins with accurate phenomenological classification. Once the movement type is identified, the differential can be narrowed based on age of onset, temporal course, associated features, and family history.

Step-by-Step Approach to Differential Diagnosis:

Step 1: Identify the movement phenomenology — Is it a tic, chorea, dystonia, tremor, myoclonus, or stereotypy?
Step 2: Determine temporal course — Acute, subacute, chronic progressive, or chronic stable?
Step 3: Consider age of onset — Different conditions predominate at different ages
Step 4: Look for red flags — Features suggesting urgent or serious underlying cause
Step 5: Assess for associated features — Cognitive, psychiatric, systemic involvement

Differential Diagnosis by Movement Type

Tics

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Transient tic disorder	Motor or vocal tics lasting less than 1 year; peak onset 5-7 years; spontaneous resolution	Most common; reassurance usually sufficient
COMMON	Persistent (chronic) motor or vocal tic disorder	Motor OR vocal tics (not both) lasting more than 1 year	Generally good prognosis; may improve in adolescence
COMMON	Tourette syndrome	Multiple motor AND one or more vocal tics; present more than 1 year; onset before 18 years	Often comorbid with obsessive-compulsive disorder, attention deficit hyperactivity disorder
LESS COMMON	PANDAS/PANS	Abrupt onset tics with obsessive-compulsive symptoms; temporally related to infection (streptococcal or other)	Controversial diagnosis; acute onset is key feature
LESS COMMON	Drug-induced tics	Tics following stimulant medication, anticonvulsants, or other medications	May unmask latent tic disorder; consider medication history
UNCOMMON	Autoimmune encephalitis	Tics with neuropsychiatric symptoms, seizures, movement disorder	Anti-NMDA receptor, anti-basal ganglia antibodies
UNCOMMON	Neuroacanthocytosis	Tics with chorea, self-mutilating lip/tongue biting, acanthocytes on blood smear	Typically adolescent/adult onset; progressive

Chorea

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Sydenham chorea	Post-streptococcal; generalized chorea; emotional lability; hypotonia; motor impersistence	Most common acquired chorea in children; check for rheumatic heart disease
COMMON	Cerebral palsy (dyskinetic type)	History of perinatal insult; choreoathetosis often mixed with dystonia; non-progressive	MRI shows basal ganglia injury
LESS COMMON	Drug-induced chorea	Levodopa, stimulants, antiepileptics, oral contraceptives	Review medication history carefully
LESS COMMON	Benign hereditary chorea	NKX2-1 mutations; non-progressive; onset in infancy; may have thyroid/lung involvement	Autosomal dominant; consider if stable chorea from early childhood
LESS COMMON	Autoimmune chorea (non-Sydenham)	Anti-NMDA receptor encephalitis; systemic lupus erythematosus; antiphospholipid syndrome	Look for other autoimmune features; may have psychiatric symptoms
UNCOMMON BUT SERIOUS	Juvenile Huntington disease	Rigidity and dystonia more prominent than chorea; cognitive decline; seizures; parkinsonism	Family history (may be unknown); CAG repeat more than 60; progressive
UNCOMMON BUT SERIOUS	Wilson disease	Chorea with dystonia, tremor, parkinsonism; Kayser-Fleischer rings; liver disease	MUST screen in any adolescent with new movement disorder
UNCOMMON	Metabolic/mitochondrial	Glutaric aciduria type 1, Lesch-Nyhan, mitochondrial disorders	Often with other neurological features; may be episodic

Dystonia

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Cerebral palsy (dyskinetic/dystonic)	Perinatal history; early-onset; often generalized; non-progressive after initial period	Most common cause of secondary dystonia in children
COMMON	Acute dystonic reaction	Acute onset hours after dopamine-blocking drug; sustained posturing; distressing	Emergency — responds rapidly to anticholinergics
LESS COMMON	Dopa-responsive dystonia (Segawa disease)	Childhood onset; diurnal fluctuation; dystonic gait; dramatic response to low-dose levodopa	MUST trial levodopa in any child with unexplained dystonia
LESS COMMON	DYT1 dystonia	Onset typically 8-12 years; starts in limb; often generalizes; Ashkenazi Jewish predilection	Autosomal dominant; GAG deletion in TOR1A gene
LESS COMMON	Myoclonus-dystonia (DYT11)	Dystonia with myoclonus; often cervical/brachial; alcohol-responsive	SGCE mutations; psychiatric comorbidity common
UNCOMMON BUT SERIOUS	Wilson disease	Adolescent onset; dystonia with tremor, parkinsonism; Kayser-Fleischer rings	Treatable — early diagnosis critical
UNCOMMON BUT SERIOUS	Neurodegeneration with brain iron accumulation (NBIA)	Progressive dystonia; cognitive decline; “eye of tiger” sign on MRI	PANK2 most common; also PLA2G6, others
UNCOMMON	Glutaric aciduria type 1	Acute dystonia after illness; macrocephaly; “bat wing” appearance of ventricles	Metabolic emergency; newborn screening available in some regions
UNCOMMON	Neurotransmitter disorders	Dopamine synthesis defects; oculogyric crises; variable response to levodopa	CSF neurotransmitter analysis diagnostic

Tremor

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Enhanced physiological tremor	Fine, fast tremor; worsened by anxiety, caffeine, medications, hyperthyroidism	No treatment usually needed; address underlying cause
COMMON	Essential tremor	Postural and kinetic tremor; often family history; may affect head/voice; improves with alcohol	Can begin in childhood; generally benign course
LESS COMMON	Dystonic tremor	Tremor in body part affected by dystonia; irregular; position-specific	Look carefully for subtle dystonia
LESS COMMON	Drug-induced tremor	Valproate, lithium, stimulants, bronchodilators, SSRIs	Review medication list
LESS COMMON	Cerebellar tremor	Intention tremor; worsens approaching target; associated ataxia	Suggests cerebellar pathology
UNCOMMON BUT SERIOUS	Wilson disease	“Wing-beating” tremor; may have rest, postural, or action component	Screen all adolescents with tremor
UNCOMMON	Functional tremor	Variable frequency; distractible; entrainment with rhythmic movements	Increasingly recognized in adolescents

Myoclonus

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Benign sleep myoclonus of infancy	Repetitive jerks during sleep only; onset in first months; resolves by 6 months	EEG normal; no treatment needed; reassure parents
COMMON	Benign myoclonus of early infancy (Fejerman syndrome)	Brief clusters of myoclonus while awake; normal development; resolves by 2 years	Often mistaken for infantile spasms; EEG normal
COMMON	Juvenile myoclonic epilepsy	Myoclonic jerks especially in morning; onset adolescence; may have generalized tonic-clonic seizures	EEG shows generalized polyspike-wave; lifelong treatment usually needed
LESS COMMON	Opsoclonus-myoclonus syndrome	Myoclonus with opsoclonus (dancing eyes), ataxia; may follow viral illness or neuroblastoma	Screen for neuroblastoma in young children; immunotherapy may help
LESS COMMON	Hyperekplexia	Exaggerated startle; neonatal hypertonia; may cause apnea; improves with age	Glycine receptor mutations; responds to clonazepam
UNCOMMON BUT SERIOUS	Progressive myoclonic epilepsies	Myoclonus with epilepsy, cognitive decline, ataxia; progressive	Unverricht-Lundborg, Lafora, neuronal ceroid lipofuscinosis, sialidosis
UNCOMMON	Myoclonus-dystonia	Myoclonus with dystonia; alcohol-responsive; psychiatric features	SGCE mutations

Stereotypies

Probability	Condition	Key Features	Red Flags/Notes
COMMON	Primary motor stereotypies	Hand flapping, waving, finger wiggling; typically developing child; suppressible; during excitement	Normal neurological exam; normal development; generally benign
COMMON	Stereotypies in autism spectrum disorder	Hand flapping, rocking, spinning; associated with communication and social deficits	Part of autism spectrum disorder; address underlying condition
LESS COMMON	Stereotypies in intellectual disability	May be more complex; body rocking; head banging	Consider genetic testing for underlying cause
UNCOMMON	Rett syndrome	Hand-wringing stereotypies; developmental regression; girls predominantly	MECP2 mutations; loss of purposeful hand use

Differential by Age of Onset

Age Group	Common Conditions	Key Considerations
Neonates (0-28 days)	Benign neonatal sleep myoclonus, hyperekplexia, jitteriness, drug withdrawal, hypoxic-ischemic encephalopathy, inborn errors of metabolism, neonatal seizures	Distinguish from seizures; metabolic workup if symptomatic; many benign conditions
Infants (1-12 months)	Benign myoclonus of early infancy, infantile spasms, Sandifer syndrome, shuddering attacks, early-onset dystonia, spasmus nutans	Infantile spasms are urgent; paroxysmal torticollis benign but can mimic posterior fossa tumor
Toddlers (1-3 years)	Stereotypies, transient tics, breath-holding spells, cerebral palsy becomes apparent, Rett syndrome, glutaric aciduria	Stereotypies often emerge at this age; regression red flag for Rett, neurodegenerative disease
Preschool/Early school (4-7 years)	Tics (peak onset), Sydenham chorea, PANDAS/PANS, DYT1 dystonia beginning, functional movements	Tic disorders most commonly present; post-streptococcal syndromes
School age (8-12 years)	Tics (may worsen before improvement), Tourette syndrome diagnosis, DYT1 dystonia, dopa-responsive dystonia, Wilson disease (can present)	Tourette syndrome typically diagnosed by this age; dystonia may generalize
Adolescents (13-18 years)	Wilson disease, juvenile Huntington, essential tremor, juvenile myoclonic epilepsy, functional movement disorders, NBIA	Wilson disease screening MANDATORY; functional movements increasingly common; consider adult-onset conditions

Anatomical Approach to Localization

Basal Ganglia

Chorea (striatal)

Dystonia (putamen, globus pallidus)

Hemiballismus (subthalamic nucleus)

Parkinsonism (substantia nigra)

Tics (striato-thalamo-cortical circuits)

Cerebellum

Intention tremor

Ataxia

Some dystonia (network involvement)

Titubation (cerebellar tremor of head/trunk)

Dysmetria

Cortex

Cortical myoclonus

Epilepsia partialis continua

Some focal dystonia

Asterixis (negative myoclonus)

Alien limb (rare in children)

Brainstem/Spinal Cord

Reticular myoclonus

Palatal tremor/myoclonus

Hyperekplexia

Spinal myoclonus

Propriospinal myoclonus

Drug-Induced Movement Disorders

Drug Class	Movement Type	Timing	Management
Dopamine blockers (metoclopramide, prochlorperazine, haloperidol, risperidone)	Acute dystonic reaction; akathisia; parkinsonism; tardive dyskinesia	Acute: hours-days. Tardive: months-years	Acute: anticholinergics (diphenhydramine, benztropine). Tardive: discontinue if possible
Stimulants (methylphenidate, amphetamines)	Tics (unmasking or worsening); stereotypies; chorea (overdose)	Days to weeks	Reduce dose or change medication; tics may persist after stopping
Anticonvulsants (phenytoin, carbamazepine, valproate)	Tremor (valproate); chorea (phenytoin toxicity); asterixis	Variable; often dose-related	Reduce dose; check drug levels
SSRIs/SNRIs	Tremor; akathisia; myoclonus (serotonin syndrome); bruxism	Days to weeks	Dose reduction; switch medication
Levodopa	Dyskinesia (in treated patients with dopa-responsive conditions or Parkinson disease)	Months to years of treatment	Adjust dosing; amantadine may help
Bronchodilators (salbutamol/albuterol)	Tremor	Hours after dose	Usually transient; reduce frequency if problematic
Lithium	Tremor; chorea (toxicity)	Tremor: early. Chorea: with toxicity	Check lithium level; reduce dose

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Chorea following sore throat (1-6 months prior)	Sydenham chorea	ASO titer, anti-DNase B, echocardiogram
Dystonia hours after metoclopramide	Acute dystonic reaction	Give IV diphenhydramine or benztropine immediately
Dystonic gait worse in evening, better after sleep	Dopa-responsive dystonia	Trial of low-dose levodopa
Adolescent with tremor and psychiatric changes	Wilson disease	Slit-lamp exam, ceruloplasmin, 24-hour urine copper
Movement disorder with cognitive decline and seizures	Progressive myoclonic epilepsy or neurodegenerative disease	EEG, MRI, metabolic workup, genetic testing
Hemichorea/hemidystonia, acute onset	Contralateral structural lesion (stroke, tumor)	Urgent brain MRI
Repetitive movements only during sleep in infant	Benign neonatal sleep myoclonus	EEG to rule out seizures; reassurance
Tics with abrupt onset and OCD symptoms	PANDAS/PANS	Strep testing, consider anti-neuronal antibodies
Hand-wringing stereotypies with developmental regression in girl	Rett syndrome	MECP2 genetic testing
Movement disorder with self-mutilation (lip/finger biting)	Lesch-Nyhan syndrome	Uric acid level, HPRT enzyme assay
“Eye of the tiger” sign on MRI	Pantothenate kinase-associated neurodegeneration (NBIA)	PANK2 genetic testing
Movement disorder with macrocephaly after illness	Glutaric aciduria type 1	Urine organic acids, acylcarnitine profile, GCDH gene testing

Red Flag Diagnoses: Do Not Miss

Treatable conditions:

Wilson disease — screen ALL adolescents with movement disorder
Dopa-responsive dystonia — trial levodopa in all unexplained childhood dystonia
Autoimmune encephalitis — early immunotherapy improves outcomes
Sydenham chorea — secondary prophylaxis prevents cardiac damage

Urgent evaluation needed:

Acute dystonic reaction — treat immediately
Status dystonicus — life-threatening emergency
Structural lesions — hemichorea/hemidystonia suggests stroke or tumor
Opsoclonus-myoclonus — may indicate occult neuroblastoma

6. Diagnostic Investigations

A stepwise, clinical suspicion-guided approach to investigating pediatric movement disorders

Investigation Principles for Pediatric Movement Disorders:

Clinical diagnosis first: Accurate phenomenological classification guides targeted testing
Treatable conditions priority: Always exclude Wilson disease and dopa-responsive dystonia early
Stepwise approach: Start with basic tests; proceed to advanced investigations based on clinical suspicion
Minimize radiation: Use MRI rather than CT when possible in children
Consider sedation needs: Young children may require sedation for MRI
Genetic testing evolution: Next-generation sequencing panels and whole exome/genome sequencing increasingly first-line for unexplained cases

Baseline Investigations for All Patients with Unexplained Movement Disorders

Investigation	Purpose	What to Look For	Practical Points
Complete blood count with peripheral smear	Screen for hematological abnormalities, acanthocytes	Acanthocytes (neuroacanthocytosis); anemia (Wilson disease)	Request manual smear review for acanthocytes if clinically suspected
Comprehensive metabolic panel	Electrolytes, glucose, liver and kidney function	Hypoglycemia; hepatic dysfunction (Wilson disease); renal impairment	Liver enzymes may be elevated in Wilson disease before neurological symptoms
Thyroid function tests	Exclude thyroid disease	Hyperthyroidism causes tremor; hypothyroidism causes movement slowing	TSH, free T4
Ceruloplasmin	Screen for Wilson disease	Low ceruloplasmin (typically less than 20 mg/dL)	MUST check in ALL adolescents with new movement disorder; can be normal in 5% of Wilson disease
Brain MRI with and without contrast	Structural evaluation; specific patterns for various conditions	Basal ganglia changes; iron deposition; white matter abnormalities; cerebellar atrophy	Include susceptibility-weighted imaging (SWI) for iron; consider sedation in young children
EEG	Rule out epileptic etiology; characterize myoclonus	Epileptiform discharges; EEG correlate of myoclonus; slow background (encephalopathy)	Video-EEG preferred to capture events; sleep-deprived if myoclonus

Mandatory Wilson Disease Screening

Every child or adolescent (especially ages 5-40) presenting with unexplained movement disorder MUST be screened for Wilson disease. It is treatable and fatal if missed.

Wilson disease screening panel:

Serum ceruloplasmin (low in most cases, but normal does NOT exclude)
24-hour urine copper (elevated more than 100 μg/24h suggestive; more than 40 μg/24h in children warrants further evaluation)
Slit-lamp examination for Kayser-Fleischer rings (present in approximately 95% with neurological Wilson disease)
Serum copper (may be low or normal)
Liver function tests

If any abnormality or high clinical suspicion: ATP7B gene sequencing, liver biopsy for copper quantification

Targeted Investigations by Suspected Etiology

If Suspecting Sydenham Chorea / Post-Streptococcal Disorder

First-Line Tests

Anti-streptolysin O (ASO) titer: Elevated in 80% (may have normalized)
Anti-DNase B antibody: More sensitive, stays elevated longer
Throat culture: May be positive for group A streptococcus
Echocardiogram: Essential to evaluate for rheumatic heart disease

Additional Tests

ECG: Prolonged PR interval suggests carditis
Inflammatory markers: ESR, CRP (may be elevated)
Brain MRI: May show reversible striatal changes
Anti-basal ganglia antibodies: Research setting; not routinely available

If Suspecting Dystonia

Essential First-Line Tests

Levodopa trial: ALL children with unexplained dystonia should receive a trial of levodopa (diagnostic and therapeutic for dopa-responsive dystonia)
Wilson disease screening: Ceruloplasmin, 24-hour urine copper, slit-lamp exam
Brain MRI: Look for structural lesions, iron accumulation, metabolic patterns

Second-Line Tests

Genetic testing: DYT gene panel or movement disorder gene panel; whole exome sequencing if panel negative
CSF neurotransmitter metabolites: If considering neurotransmitter synthesis defects (requires special collection)
Metabolic workup: Organic acids, amino acids, acylcarnitines if metabolic cause suspected

Clinical Pearl: The Levodopa Trial

Every child with unexplained dystonia deserves a trial of levodopa.

Protocol: Start low-dose levodopa/carbidopa (1-2 mg/kg/day of levodopa) and titrate slowly
Response: Dramatic improvement within days to weeks in dopa-responsive dystonia
Duration: Trial for at least 3 months at adequate dose before concluding negative
Side effects: Nausea, dyskinesia at higher doses — start low

Dopa-responsive dystonia is one of the few treatable genetic movement disorders — missing it has lifelong consequences.

If Suspecting Autoimmune/Inflammatory Etiology

Test	What It Detects	Conditions
Anti-NMDA receptor antibodies	Antibodies against NR1 subunit	Anti-NMDA receptor encephalitis (movement disorder, psychiatric symptoms, seizures)
Anti-neuronal antibodies panel	Various cell-surface and intracellular antibodies	Autoimmune encephalitis, paraneoplastic syndromes
CSF analysis	Pleocytosis, protein, oligoclonal bands, antibodies	Inflammatory/autoimmune conditions; send CSF for antibodies
ANA, anti-dsDNA, complement levels	Systemic lupus erythematosus markers	Lupus chorea, CNS lupus
Antiphospholipid antibodies	Lupus anticoagulant, anticardiolipin, anti-β2 glycoprotein	Antiphospholipid syndrome with chorea
Tumor markers and imaging	Neuroblastoma workup in young children	Opsoclonus-myoclonus syndrome — check urine catecholamines, chest/abdominal MRI or CT

If Suspecting Metabolic/Neurodegeneration

Investigation	What It Tests	Conditions Detected
Urine organic acids	Metabolic intermediates	Glutaric aciduria type 1, methylmalonic acidemia, propionic acidemia
Plasma amino acids	Amino acid metabolism	Homocystinuria, maple syrup urine disease variants
Acylcarnitine profile	Fatty acid and organic acid metabolism	Glutaric aciduria type 1, fatty acid oxidation defects
Lactate and pyruvate	Mitochondrial function	Mitochondrial disorders (elevated lactate, elevated lactate:pyruvate ratio)
Uric acid	Purine metabolism	Lesch-Nyhan syndrome (elevated); molybdenum cofactor deficiency (low)
Lysosomal enzyme panel	Lysosomal storage enzyme activities	Niemann-Pick type C (filipin staining, oxysterols), GM1/GM2 gangliosidosis, Gaucher
Very long chain fatty acids	Peroxisomal function	Adrenoleukodystrophy, peroxisomal disorders
CSF neurotransmitter metabolites	Dopamine, serotonin, tetrahydrobiopterin metabolites	Neurotransmitter synthesis defects (requires special collection protocol — freeze immediately)
Alpha-fetoprotein	Elevated in certain conditions	Ataxia-telangiectasia (elevated)

If Suspecting Genetic Etiology

Targeted Gene Testing

DYT1 (TOR1A): Early-onset generalized dystonia
GCH1: Dopa-responsive dystonia
SGCE: Myoclonus-dystonia
NKX2-1: Benign hereditary chorea
HTT (CAG repeats): Huntington disease
ATP7B: Wilson disease
PANK2: Pantothenate kinase-associated neurodegeneration
MECP2: Rett syndrome

Broad Genetic Testing

Movement disorder gene panel: Tests 100+ genes associated with movement disorders
Whole exome sequencing (WES): When targeted testing negative; increasingly first-line
Whole genome sequencing (WGS): Most comprehensive; detects structural variants
Chromosomal microarray: Copy number variants; useful if dysmorphic features
Mitochondrial DNA sequencing: If mitochondrial disorder suspected

Neuroimaging: MRI Findings by Condition

Condition	Key MRI Findings	Sequences to Request
Kernicterus	Bilateral globus pallidus T2 hyperintensity	T2, FLAIR
Hypoxic-ischemic encephalopathy	Basal ganglia and thalamus T2 hyperintensity; periventricular white matter changes	T1, T2, DWI (in acute phase)
Wilson disease	“Face of giant panda” sign in midbrain; putaminal T2 hyperintensity; may have cortical atrophy	T2, FLAIR, T1
NBIA (PKAN)	“Eye of the tiger” sign — globus pallidus hypointensity with central hyperintensity	T2, SWI (susceptibility-weighted imaging)
Glutaric aciduria type 1	“Bat wing” frontotemporal atrophy; widened Sylvian fissures; striatal changes after metabolic crisis	T1, T2
Juvenile Huntington disease	Caudate atrophy; may have striatal hyperintensity	T1, T2, volumetric
Sydenham chorea	May be normal; reversible striatal hyperintensity/enlargement in some cases	T2, FLAIR
Leigh syndrome (mitochondrial)	Bilateral symmetric basal ganglia and brainstem T2 hyperintensity	T2, FLAIR, MR spectroscopy (lactate peak)
Neuronal ceroid lipofuscinosis	Cerebral and cerebellar atrophy; thalamic T2 hypointensity	T1, T2
Dopa-responsive dystonia	Usually NORMAL	Standard MRI to exclude other causes

MRI Protocol for Movement Disorders

Request specific sequences when investigating movement disorders:

Standard sequences: T1, T2, FLAIR, DWI
SWI (Susceptibility-Weighted Imaging): Essential for detecting iron deposition (NBIA, neurodegeneration)
MR Spectroscopy: Useful if mitochondrial disorder suspected (lactate peak)
Thin-cut through basal ganglia: Better visualization of subtle changes
With and without contrast: If tumor, inflammation, or infection suspected

EEG: When and What to Look For

Clinical Scenario	EEG Purpose	Expected Findings
Differentiating myoclonus from seizures	Determine if epileptic or non-epileptic	Cortical myoclonus: time-locked EEG discharge. Subcortical/spinal: no EEG correlate
Suspected infantile spasms	Diagnosis and classification	Hypsarrhythmia pattern
Suspected juvenile myoclonic epilepsy	Confirm epilepsy syndrome	Generalized 4-6 Hz polyspike-wave discharges
Progressive myoclonic epilepsy	Characterize epilepsy; assess background	Slowing background; generalized discharges; photosensitivity
Benign sleep myoclonus	Rule out seizures	Normal EEG during myoclonic events; normal background
Encephalopathy with movement disorder	Assess for seizures; evaluate background	Slowing suggests encephalopathy; extreme delta brush in anti-NMDA receptor encephalitis

Empiric Treatment Trials as Diagnostic Tools

Therapeutic Trials as Diagnostic Tools

In pediatric movement disorders, response to specific treatments can be diagnostic:

Levodopa trial for dystonia:
- Start levodopa/carbidopa 1-2 mg/kg/day of levodopa
- Titrate every 1-2 weeks
- Dramatic response confirms dopa-responsive dystonia
- Trial for at least 3 months at adequate dose
Anticholinergics for acute dystonic reaction:
- IV diphenhydramine 1 mg/kg (max 50 mg) or benztropine 1-2 mg
- Rapid response (minutes) confirms drug-induced acute dystonia
Clonazepam for hyperekplexia:
- Good response supports diagnosis
- Confirm with genetic testing (GLRA1, GLRB)

Investigation Algorithm by Presentation

Algorithm for Acute-Onset Movement Disorder

Stabilize the patient — assess airway, breathing, circulation
Detailed medication history — dopamine blockers? Recent changes?
If acute dystonic reaction suspected: Give anticholinergics (diphenhydramine IV)
Basic labs: Glucose, electrolytes, liver/renal function, CBC, toxicology screen
Brain imaging: CT head urgently if focal signs or altered consciousness; MRI when stable
If encephalopathy: Lumbar puncture (after imaging); autoimmune antibody panel
If infection suspected: CSF studies including cultures, viral PCR panel

Algorithm for Chronic/Progressive Movement Disorder

Baseline investigations: CBC, CMP, TFTs, ceruloplasmin, MRI brain
Wilson disease screen: Ceruloplasmin, 24-hour urine copper, slit-lamp exam
If dystonia: Trial of levodopa
If progressive or cognitive decline: Metabolic workup (organic acids, amino acids, lactate, lysosomal enzymes)
Genetic testing: Movement disorder gene panel or whole exome sequencing
If ataxia component: Alpha-fetoprotein (ataxia-telangiectasia), vitamin E level
If myoclonus: EEG to characterize; if progressive, consider progressive myoclonic epilepsy workup

Pediatric-Specific Investigation Considerations

Consideration	Practical Approach
Sedation for MRI	Many children under age 6-7 require sedation; coordinate with anesthesia; ensure airway monitoring
Blood volume limitations	Prioritize tests; use microtainers when possible; coordinate draws to minimize total volume
24-hour urine collection	Challenging in young children; ensure complete collection; may need catheter in some cases
CSF collection for neurotransmitters	Requires special handling — freeze immediately at bedside; coordinate with lab beforehand
Genetic counseling	Offer genetic counseling before and after testing; implications for family members
Newborn screening results	Review newborn screen results — some metabolic conditions detectable at birth

Clinical Pearl: When to Consider Whole Exome/Genome Sequencing

Next-generation sequencing is increasingly first-line for unexplained pediatric movement disorders:

Early childhood onset with no clear acquired cause
Family history suggestive of genetic condition
Multiple affected systems (movement disorder plus cognitive/developmental/systemic involvement)
Targeted testing negative but high suspicion for genetic cause
Consanguineous family — increased likelihood of rare recessive conditions

Trio testing (child + both parents) improves diagnostic yield and helps interpret variants.

7. Clinical Decision-Making

Practical algorithms, triage pathways, and decision frameworks for pediatric movement disorders

Step 1: Is This Urgent?

The first priority is identifying children who require immediate intervention or urgent evaluation.

Clinical Scenario	Urgency Level	Immediate Action	Rationale
Acute dystonic reaction — sustained posturing after dopamine-blocking medication	EMERGENT	IV diphenhydramine 1 mg/kg (max 50 mg) or benztropine 1-2 mg IV/IM immediately	Highly distressing; risk of laryngospasm; rapidly reversible with treatment
Status dystonicus — severe sustained dystonia with hyperthermia, respiratory compromise, or rhabdomyolysis	EMERGENT	ICU admission; IV hydration; sedation; monitor creatine kinase and renal function; consider intubation	Life-threatening; risk of renal failure, respiratory failure, death
Movement disorder with altered consciousness	EMERGENT	Stabilize; glucose check; toxicology screen; urgent neuroimaging; consider lumbar puncture	May indicate encephalitis, intoxication, metabolic crisis, stroke
Acute hemichorea/hemidystonia	EMERGENT	Urgent brain MRI/CT; evaluate for stroke, tumor, demyelination	Unilateral movement disorder suggests structural lesion requiring immediate evaluation
Movement disorder with fever and encephalopathy	URGENT	Admit; infectious and autoimmune workup; consider empiric antibiotics/antivirals	May indicate encephalitis (infectious or autoimmune)
New chorea in child with recent sore throat	URGENT	Streptococcal antibodies; echocardiogram; cardiology consultation	Sydenham chorea — must evaluate for rheumatic heart disease
Adolescent with new movement disorder	URGENT	Wilson disease screening (ceruloplasmin, urine copper, slit-lamp exam)	Wilson disease is treatable and fatal if missed; early treatment prevents progression
Movement disorder with developmental regression	URGENT	Expedited metabolic and genetic workup; brain MRI	Suggests neurodegenerative or neurometabolic disease; some are treatable if caught early
Opsoclonus-myoclonus in young child	URGENT	Neuroblastoma screen (urine catecholamines, chest/abdominal imaging)	May indicate occult neuroblastoma; early treatment improves outcomes
Stable, chronic movement disorder	ROUTINE	Outpatient evaluation with pediatric neurology	Allows thorough workup; most primary movement disorders are not emergencies
Typical tics in school-age child	ROUTINE	Reassurance; monitor; refer if severe or impairing	Most tics are benign and self-limited; treatment only if functionally impairing

Step 2: Classify the Movement

Accurate phenomenological classification is essential for guiding diagnosis and treatment.

Hyperkinetic (Excess Movement)

Tics
Chorea
Dystonia
Tremor
Myoclonus
Stereotypies
Athetosis
Ballismus

Most common in children

Hypokinetic (Reduced Movement)

Parkinsonism
Bradykinesia
Rigidity
Akinesia

Rare in children; think Wilson disease, juvenile Huntington, drug-induced

Mixed Phenotypes

Dystonia + chorea
Dystonia + parkinsonism
Myoclonus + dystonia
Tremor + dystonia

Common in children; identify predominant type

Step 3: Determine the Temporal Course

Temporal Pattern	Duration	Key Questions	Diagnostic Pathway
Acute	Hours to days	New medication? Illness? Trauma? Ingestion?	Drug-induced, toxic, infectious, structural (stroke) → Urgent workup
Subacute	Days to weeks	Recent infection? Behavioral changes? Fever?	Autoimmune, post-infectious, inflammatory → Autoimmune panel, MRI
Chronic Progressive	Months to years, worsening	Losing skills? Cognitive decline? Family history?	Neurodegenerative, metabolic, genetic → Extensive metabolic/genetic workup
Chronic Stable	Stable over time	Birth/perinatal history? Static since onset?	Cerebral palsy, primary genetic, essential tremor → Focused workup
Paroxysmal	Episodic with normal intervals	Triggers? Duration of episodes? Family history?	Paroxysmal dyskinesias, channelopathies → Genetic testing, video capture
Waxing and Waning	Fluctuating severity	Good days and bad days? Stress-related?	Tics, functional movements → Clinical diagnosis often sufficient

Step 4: Decision Algorithms by Movement Type

Algorithm A: Child with Tics

Confirm tic phenomenology: Brief, sudden, stereotyped movements; premonitory urge; temporarily suppressible
Classify: Motor only? Vocal only? Both? Duration more than 1 year?
Assess functional impact: Interfering with school, social life, or causing distress?
Screen for comorbidities: Obsessive-compulsive disorder, attention deficit hyperactivity disorder, anxiety, depression
If typical presentation: Neurological examination; no routine investigations needed
Red flags requiring investigation: Atypical features, acute onset, progressive course, neurological signs
Treatment decision: Education and reassurance for mild tics; behavioral therapy (CBIT) for moderate; medications for severe/impairing

Algorithm B: Child with Chorea

Acute/subacute onset: Consider Sydenham chorea, autoimmune, drug-induced → Strep antibodies, autoimmune panel, medication review
Sydenham chorea suspected: ASO, anti-DNase B, echocardiogram MANDATORY
Chronic from early childhood: Consider cerebral palsy (perinatal history?), benign hereditary chorea
Progressive with cognitive decline: Consider Wilson disease, juvenile Huntington → Wilson screen in ALL adolescents; HTT gene testing if suspected
Associated neuropsychiatric symptoms: Consider autoimmune encephalitis → Anti-neuronal antibodies
MRI brain: All cases of unexplained chorea

Algorithm C: Child with Dystonia

Acute onset after medication: Acute dystonic reaction → Treat with anticholinergics immediately
ALL unexplained childhood dystonia: Trial of levodopa (dopa-responsive dystonia is treatable and must not be missed)
Wilson disease screen: MANDATORY for any adolescent with dystonia
Brain MRI: Look for structural lesions, iron accumulation, metabolic patterns
If early childhood onset, static: Evaluate for cerebral palsy (birth history, MRI)
If progressive or no clear cause: Genetic testing (DYT gene panel → whole exome sequencing)
If diurnal fluctuation (worse in PM, better after sleep): Strongly suspect dopa-responsive dystonia

Algorithm D: Child with Tremor

Review medications: Valproate, stimulants, bronchodilators, SSRIs?
Check thyroid function: Hyperthyroidism causes tremor
Characterize tremor: Rest? Postural? Action/intention?
If postural/action with family history: Consider essential tremor
If intention tremor with ataxia: Cerebellar pathology → MRI brain
If adolescent: Wilson disease screen MANDATORY
If associated dystonic posturing: Consider dystonic tremor
If variable, distractible, inconsistent: Consider functional tremor

Algorithm E: Infant/Young Child with Abnormal Movements

First priority: Distinguish from seizures — EEG if any doubt
If movements only during sleep: Consider benign sleep myoclonus (EEG normal)
If brief clusters while awake, normal development: Consider benign myoclonus of early infancy
If episodic head tilt: Consider paroxysmal torticollis of infancy (benign) vs posterior fossa lesion → MRI if atypical
If exaggerated startle: Consider hyperekplexia → genetic testing, trial of clonazepam
If developmental concerns or regression: Metabolic and genetic workup urgently
If perinatal risk factors + abnormal tone/movements: Evaluate for cerebral palsy (MRI brain)

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Child has acute dystonic reaction in emergency department	IV diphenhydramine 1 mg/kg or benztropine 1-2 mg immediately	Identify causative medication; educate family; document allergy/adverse reaction
Adolescent presents with new tremor and behavioral changes	Order ceruloplasmin, 24-hour urine copper, LFTs; arrange slit-lamp exam	If Wilson disease confirmed, urgent hepatology and neurology referral; start treatment
Parents are very anxious about child’s tics	Provide education; explain natural history (most improve); validate concerns	Screen for comorbidities; refer if functionally impairing; reassess in 3-6 months
Child with dystonia not responding to levodopa	Ensure adequate dose and duration (at least 3 months); check compliance	Proceed with genetic testing; consider other treatments (anticholinergics, botulinum toxin, DBS evaluation)
Movement disorder with progressive cognitive decline	Expedite workup: MRI, metabolic panel, genetic testing	Consider storage disorders, NBIA, mitochondrial disease, Huntington; refer to metabolic/genetics specialist
Chorea following strep infection	Order echocardiogram TODAY; start secondary prophylaxis with penicillin	Cardiology referral; long-term secondary prophylaxis; symptomatic treatment if needed
Infant with movements concerning for seizures	Obtain EEG (video-EEG preferred)	If EEG normal during events: likely not seizures (consider benign movement variants); if abnormal: treat epilepsy
Child with tics started on stimulant medication	Tics may be unmasked or worsened; does not contraindicate stimulants if ADHD significant	If tics tolerable: continue stimulant with monitoring; if severe: consider dose reduction or alternative ADHD treatment
Family history of Huntington disease and child has movement disorder	Genetic counseling BEFORE testing; discuss implications	CAG repeat testing if appropriate; juvenile HD presents differently (more rigidity, less chorea)
Functional movement disorder suspected	Document positive signs (distractibility, entrainment, inconsistency); avoid excessive testing	Explain diagnosis positively; refer to multidisciplinary team (psychology, physiotherapy); avoid reinforcing sick role

When to Refer to Pediatric Neurology

Urgent Referral

Any movement disorder with developmental regression
Acute-onset movement disorder without clear drug cause
Movement disorder with altered mental status
Suspected Wilson disease
Hemichorea or hemidystonia
Movement disorder with seizures
Opsoclonus-myoclonus syndrome

Routine Referral

Tics causing functional impairment
Tourette syndrome for management guidance
Unexplained dystonia (for levodopa trial, workup)
Stereotypies with developmental concerns
Tremor affecting function
Movement disorder requiring treatment
Diagnostic uncertainty

Troubleshooting: Refractory Movement Disorders

When Treatment Isn’t Working — Ask These Questions

Is the diagnosis correct? Re-examine the phenomenology; review video; consider alternative diagnoses
Are there multiple overlapping movement disorders? Common in children — may need multiple treatments
Is there a functional component? Functional overlay can complicate organic movement disorders
Has Wilson disease been excluded? Re-check if not done or if testing was equivocal
Was the levodopa trial adequate? Sufficient dose? Long enough duration? Good compliance?
Are there untreated comorbidities? Anxiety, depression, pain can worsen movement disorders
Is the medication regimen optimized? Consider drug interactions, timing, formulations
Are there environmental factors? Stress, sleep deprivation, caffeine can worsen movements
Should advanced therapies be considered? Botulinum toxin for focal dystonia; deep brain stimulation for severe generalized dystonia

Special Considerations: Functional Movement Disorders

Recognizing and Managing Functional Movement Disorders in Children

Functional movement disorders are increasingly recognized in pediatrics and require specific management:

Positive diagnostic signs:

Distractibility — movements diminish or change with distraction
Entrainment — tremor takes on frequency of externally paced movement
Variability — inconsistent phenomenology over time
Suggestibility — movements can be induced or modified by suggestion
Disappearance with specific maneuvers

Management principles:

Explain diagnosis positively — the brain is not damaged but is not working correctly; this is treatable
Avoid excessive investigation once diagnosis is confident
Physiotherapy with movement retraining
Psychology support — address underlying stressors
Avoid reinforcing sick role
Prognosis is generally good in children with early intervention

8. Clinical Pearls and Pitfalls

Practical wisdom for approaching pediatric movement disorders — learn from experience

Must-Know Clinical Pearls

Wilson disease screening is mandatory: Every adolescent presenting with a new movement disorder (tremor, dystonia, chorea, parkinsonism) MUST be screened for Wilson disease. It is treatable, and missing it is fatal. A single ceruloplasmin is not sufficient — include slit-lamp examination and 24-hour urine copper.

Every child with unexplained dystonia deserves a levodopa trial: Dopa-responsive dystonia is one of the most treatable movement disorders. Low-dose levodopa produces dramatic, sustained improvement. Trial for at least 3 months at adequate dose before concluding it is negative.

Video documentation is invaluable: Movement disorders are intermittent and variable. Always ask parents for home videos. Record movements in clinic. Video allows re-review, expert consultation, and tracking response to treatment.

Tics are the most common movement disorder in children: Peak onset is 5-7 years. Most are transient and benign. Reassurance and education are often the only treatment needed. Treatment is indicated only when tics are functionally impairing.

Acute dystonic reaction responds immediately to anticholinergics: A child with sustained posturing hours after metoclopramide or an antipsychotic needs IV diphenhydramine or benztropine immediately — not extensive workup. The response is diagnostic.

Sydenham chorea means echocardiogram today: Chorea following streptococcal infection is Sydenham chorea until proven otherwise. The movement disorder will resolve, but undetected rheumatic heart disease can be lifelong. Order the echocardiogram immediately.

Mixed movement disorders are common in children: Unlike adults, children often have dystonia plus chorea, or tremor plus dystonia. Identify the predominant movement type but be aware that single-mechanism thinking may not apply.

Diurnal fluctuation suggests dopa-responsive dystonia: If the child walks better in the morning than the evening, or improves dramatically after sleep, think dopa-responsive dystonia. This classic pattern should prompt immediate levodopa trial.

Sleep abolishes tics and stereotypies: If the movement persists during sleep, it is not a tic or stereotypy. This history point helps distinguish tics from myoclonus or other movements that may persist in sleep.

Premonitory urge is highly specific for tics: The sensation of needing to perform the movement, followed by relief after performing it, is characteristic of tics and not seen in other movement disorders. Ask older children directly about this.

Critical Pitfalls to Avoid

Missing Wilson disease because ceruloplasmin was normal: Up to 5% of Wilson disease patients have normal ceruloplasmin. Always complete the full screening panel: ceruloplasmin, 24-hour urine copper, AND slit-lamp examination. When in doubt, proceed to genetic testing.

Not trying levodopa in childhood dystonia: Dopa-responsive dystonia can be completely treated with medication, but only if diagnosed. Every child with unexplained dystonia deserves an adequate levodopa trial. The consequence of missing this diagnosis is lifelong disability.

Diagnosing tics based on parent description alone: Many movements are called “tics” that are not tics. Observe the movements directly or on video. Confirm the phenomenology before labeling — stereotypies, chorea, and myoclonus are often misidentified as tics.

Forgetting to order an echocardiogram in Sydenham chorea: The chorea is obvious, but the silent carditis can cause permanent heart damage. Every patient with suspected Sydenham chorea needs an echocardiogram, regardless of whether a murmur is heard.

Assuming hemichorea/hemidystonia is benign: Unilateral movement disorder in a child is a structural lesion (stroke, tumor, demyelination) until proven otherwise. This requires urgent brain imaging, not outpatient referral.

Treating all tics with medication: Most tics do not require pharmacological treatment. Medications have side effects. Reserve medications for tics that are functionally impairing despite behavioral interventions. Education and reassurance are often sufficient.

Dismissing parental concern about infant movements: While many infant movement disorders are benign, parents often notice subtle abnormalities that warrant evaluation. Benign sleep myoclonus and Fejerman syndrome are diagnoses of exclusion — ensure EEG is normal before reassuring.

Overlooking medication causes: Metoclopramide is still prescribed to children and is a common cause of acute dystonic reactions. Stimulants can unmask tics. Always take a detailed medication history including over-the-counter and recently stopped medications.

Ordering excessive tests for typical tics: A school-age child with waxing and waning tics, suppressibility, premonitory urge, and normal neurological examination does not need an MRI, EEG, or extensive bloodwork. Clinical diagnosis is appropriate.

Forgetting neuroblastoma workup in opsoclonus-myoclonus: In a young child with opsoclonus-myoclonus syndrome, occult neuroblastoma must be excluded with urine catecholamines and chest/abdominal imaging. Early detection improves neurological outcomes.

Key Takeaways

Phenomenology first: Accurate classification of the movement type (tic, chorea, dystonia, tremor, myoclonus, stereotypy) is essential and guides all subsequent evaluation.
Wilson disease is the great mimicker: It can present with almost any movement disorder. Screen all adolescents with new movement disorders — it is one of the few treatable causes of progressive neurological disease.
Dopa-responsive dystonia must not be missed: Trial levodopa in all children with unexplained dystonia. The response is often dramatic and life-changing.
Tics are common and usually benign: Reassurance and education are the mainstay for most children with tics. Reserve medications for significant functional impairment.
Sydenham chorea = echocardiogram: The cardiac manifestations of rheumatic fever are the lasting danger. Never forget the echocardiogram.
Acute dystonic reactions are emergencies: Recognize them and treat immediately with anticholinergics. The response is rapid and diagnostic.
Video is your friend: Movements may not be present during clinic visits. Home videos are essential for diagnosis and monitoring.
Think genetic and metabolic in children: Unlike adults, pediatric movement disorders are often genetic or metabolic in origin. Early diagnosis may allow disease-modifying treatment.
Red flags demand action: Developmental regression, acute altered mental status, hemichorea/hemidystonia, and fever with movement disorder require urgent evaluation.
Multidisciplinary care improves outcomes: Complex movement disorders benefit from involvement of neurology, genetics, rehabilitation, psychology, and other specialists.

Quick Reference Algorithm

Systematic Approach to Pediatric Movement Disorders:

Identify urgency: Is this an emergency (acute dystonic reaction, status dystonicus, altered mental status, hemichorea)?
Classify the movement: What type of movement is it? Use video if needed.
Determine temporal course: Acute? Subacute? Chronic stable? Progressive?
Take detailed history: Birth history, development, medications, infections, family history.
Examine systematically: General, skin, eyes, neurological examination; look for associated signs.
Screen for treatable conditions: Wilson disease (adolescents), dopa-responsive dystonia (levodopa trial for dystonia).
Order targeted investigations: Based on clinical suspicion — not shotgun testing.
Consider genetic testing early: Next-generation sequencing is increasingly first-line for unexplained cases.
Treat and monitor: Symptomatic treatment while workup proceeds; reassess regularly.
Refer appropriately: Pediatric neurology, genetics, metabolic specialists as indicated.

Summary Tables for Quick Reference

Movement Type Recognition

Movement	Speed	Pattern	Suppressible?	Sleep
Tic	Fast	Stereotyped	Yes (briefly)	Absent
Chorea	Fast	Random, flowing	No	Usually decreased
Dystonia	Slow/sustained	Patterned, directional	No (sensory trick may help)	May persist
Tremor	Variable	Rhythmic, oscillatory	No	Usually absent
Myoclonus	Very fast	Shock-like jerks	No	May persist
Stereotypy	Variable	Highly stereotyped	Yes (with distraction)	Absent

Don’t Miss Diagnoses

Condition	Why It Matters	How to Diagnose
Wilson disease	Treatable; fatal if missed	Ceruloplasmin, urine copper, slit-lamp, genetic testing
Dopa-responsive dystonia	Completely treatable with levodopa	Levodopa trial (dramatic response)
Acute dystonic reaction	Distressing; immediately reversible	Clinical recognition; response to anticholinergics
Sydenham chorea	Cardiac involvement can be silent	Strep antibodies; echocardiogram
Autoimmune encephalitis	Immunotherapy can be disease-modifying	Anti-neuronal antibodies (serum and CSF)